Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Argus Health
Daiichi Sankyo
Queensland Health
Healthtrust
Teva
US Department of Justice
Covington
Dow

Generated: July 20, 2018

DrugPatentWatch Database Preview

Diltiazem malate - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic drug sources for diltiazem malate and what is the scope of diltiazem malate patent protection?

Diltiazem malate
is the generic ingredient in two branded drugs marketed by Merck and Biovail, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty-six drug master file entries for diltiazem malate.
Synonyms for diltiazem malate
(+)-(2S,3S)-5-(2-(Dimethylamino)ethyl)-2,3-dihydro-3-hydroxy-2-(p-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one acetate (ester),(S)-malate (1:1)
(+)-cis-5-[2-(dimethylamino)ethyl]-2,3-dihydro-3-hydroxy-2-(p-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one acetate ester
(+)-cis-diltiazem
(+)-diltiazem
(2S-cis)-3-(acetyloxy)-5-[2-(dimethylamino)ethyl]-2,3-dihydro-2-(4-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one
(2S,3S)-5-(2-(dimethylamino)ethyl)-2-(4-methoxyphenyl)-4-oxo-2,3,4,5-tetrahydrobenzo[b][1,4]thiazepin-3-yl acetate
(2S,3S)-5-[2-(dimethylamino)ethyl]-2-(4-methoxyphenyl)-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepin-3-yl acetate
(2S,3S)-5-[2-(dimethylamino)ethyl]-2-[4-(methyloxy)phenyl]-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepin-3-yl acetate
[(2S,3S)-5-(2-dimethylaminoethyl)-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-3-yl] acetate
[(2S,3S)-5-(2-dimethylaminoethyl)-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-3-yl] acetate; (2S)-2-hydroxybutanedioic acid
[(2S,3S)-5-(2-dimethylaminoethyl)-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-3-yl] acetate; 2-hydroxybutanedioic acid
[(2S,3S)-5-[2-(dimethylamino)ethyl]-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-3-yl] acetate
1,5-Benzothiazepin-4(5H)-one, 3-(acetyloxy)-5-(2-(di-methylamino)ethyl)-2,3-dihydro-2-(4-methoxyphenyl)-(2S-cis)-, (S)-hydoxybutanedioate (1:1)
1,5-Benzothiazepin-4(5H)-one, 3-(acetyloxy)-5-(2-(dimethylamino)ethyl)-2,3-dihydro-2-(4-methoxyphenyl)-, (2S-cis)-
1,5-Benzothiazepin-4(5H)-one, 3-(acetyloxy)-5-(2-(dimethylamino)ethyl)-2,3-dihydro-2-(4-methoxyphenyl)-, (2S-cis)-, (S)-hydroxybutanedioate (1:1)
1,5-Benzothiazepin-4(5H)-one, 3-(acetyloxy)-5-[2-(dimethylamino)ethyl]-2,3-dihydro-2-(4-methoxyphenyl)-, (2S,3S)-
144604-00-2
14Y6444DRP
42399-41-7
5-(2-dimethylamino-ethyl)-2-(4-methoxy-phenyl)-4-oxo-2,3,4,5-tetrahydro-benzo[b][1,4]thiazepin-3-yl ester(Diltiazem)Acetic acid
75472-92-3
8-Chloro-1-methyl-6-phenyl-4H-2,3,5,10b-tetraaza-benzo[e]azulene
AC-936
AC1L2181
AC1L52SL
AC1MI2BK
AC1Q5VDG
AC1Q6LHX
Acalix
Acetic acid (2S,3S)-5-(2-dimethylamino-ethyl)-2-(4-methoxy-phenyl)-4-oxo-2,3,4,5-tetrahydro-benzo[b][1,4]thiazepin-3-yl ester
Acetic acid (S)-5-(2-dimethylamino-ethyl)-2-(4-methoxy-phenyl)-4-oxo-2,3,4,5-tetrahydro-benzo[b][1,4]thiazepin-3-yl ester
Acetic acid 5-(2-dimethylamino-ethyl)-2-(4-methoxy-phenyl)-4-oxo-2,3,4,5-tetrahydro-benzo[b][1,4]thiazepin-3-yl ester
Acetic acid 5-(2-dimethylamino-ethyl)-2-(4-methoxy-phenyl)-4-oxo-2,3,4,5-tetrahydro-benzo[b][1,4]thiazepin-3-yl ester (Diltiazem)
Acetic acid 5-(2-dimethylamino-ethyl)-2-(4-methoxy-phenyl)-4-oxo-2,3,4,5-tetrahydro-benzo[b][1,4]thiazepin-3-yl ester; hydrochloride
Acetic acid 5-(2-dimethylamino-ethyl)-2-(4-methoxy-phenyl)-4-oxo-2,3,4,5-tetrahydro-benzo[b][1,4]thiazepin-3-yl ester(cis-(+)-Diltiazem)
Adizem
Adizem (TN)
AKOS015897257
Aldizem
Altiazem (TN)
AN-15434
Angiozem (TN)
Angizem (TN)
Angizem CD (TN)
Anoheal
API0005791
Apo-Diltiaz
BC204117
BDBM50004704
BIDD:GT0548
Bio1_000371
Bio1_000860
Bio1_001349
BPBio1_000230
BRD-K24023109-001-02-5
BRD-K24023109-003-03-9
BRN 3573079
BSPBio_000208
BSPBio_001311
C-21975
C06958
C22H26N2O4S
C22H26N2O4S.C4H6O5
Cardil
Cardizem
Cardizem (Hydrochloride)
Cardizem (TN)
Cardizen LA
Cartia XT (TN)
CAS-42399-41-7
CCG-204422
CD0163
CHEBI:101278
CHEMBL1200805
CHEMBL23
cis-Acetic acid 5-(2-dimethylamino-ethyl)-2-(4-methoxy-phenyl)-4-oxo-2,3,4,5-tetrahydro-benzo[b][1,4]thiazepin-3-yl ester
Citizem
CTK8F9218
D-(cis)-diltiazem
d-cis-Diltiazem
d-diltiazem
D03830
D07845
D0OB1J
DB00343
Dilacor
Dilacor-XR
Dilatam (TN)
Dilatem (TN)
Dilcardia (TN)
Dilcontin
Dilcontin SR (TN)
Dilren
Dilt-cd
Dilta-Hexal
Diltelan (TN)
Diltia
diltiazem
Diltiazem (INN)
Diltiazem [INN:BAN]
Diltiazem HCI
Diltiazem HCl
Diltiazem malate (USAN)
Diltiazem malate [USAN]
diltiazem;Acetic acid 5-(2-dimethylamino-ethyl)-2-(4-methoxy-phenyl)-4-oxo-2,3,4,5-tetrahydro-benzo[b][1,4]thiazepin-3-yl ester
Diltiazemum
Diltiazemum [INN-Latin]
Dilticard
Diltime (TN)
Diltzac
Dilzem
Dilzem (TN)
Dilzen
DR002508
DSSTox_CID_2940
DSSTox_GSID_22940
DSSTox_RID_76797
DTXSID9022940
Dyalec (TN)
EE92BBP03H
EINECS 255-796-4
Endrydil
Filazem (TN)
FT-0081415
FT-0625016
GTPL2298
HE342782
Herben (TN)
HMS1791B13
HMS1989B13
HMS2089H09
HSDB 6528
HSUGRBWQSSZJOP-RTWAWAEBSA-N
Incoril AP
l-Diltiazem
Lopac0_000327
LS-173219
LS-40510
MCULE-9931403933
MK-793
MK-793 (Malate)
MolPort-002-509-369
NCGC00024309-02
NCGC00024309-04
NCGC00024309-05
NCGC00024309-06
NCGC00024309-07
NCGC00024309-08
NCGC00024309-09
NCGC00024309-10
NCGC00024309-11
NCGC00024309-17
Nu-Diltiaz
Prestwick0_000134
Prestwick1_000134
Prestwick2_000134
Prestwick3_000134
Progor (TN)
RG 83606 (Hydrochloride)
RG-83606
SC-16185
SCHEMBL120772
SCHEMBL17776
SCHEMBL721521
SPBio_002147
STOCK1N-03672
Surazem (TN)
Tiamate
Tiamate (TN)
Tiazac
Tiazac (TN)
Tiazac Tildiem
Tiazac XC
Tiazac XC (TN)
Tildiem (TN)
Tocris-0685
Tox21_110898
Tox21_110898_1
UNII-14Y6444DRP
UNII-EE92BBP03H
VA10739
Vasmulax (TN)
Viazem
Viazem (TN)
W-106274
Zandil (TN)
Zemtrial (TN)
ZINC621893

US Patents and Regulatory Information for diltiazem malate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Biovail TECZEM diltiazem malate; enalapril maleate TABLET, EXTENDED RELEASE;ORAL 020507-001 Oct 4, 1996 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Merck TIAMATE diltiazem malate TABLET, EXTENDED RELEASE;ORAL 020506-001 Oct 4, 1996 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Merck TIAMATE diltiazem malate TABLET, EXTENDED RELEASE;ORAL 020506-003 Oct 4, 1996 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Merck TIAMATE diltiazem malate TABLET, EXTENDED RELEASE;ORAL 020506-002 Oct 4, 1996 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Expired US Patents for diltiazem malate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Merck TIAMATE diltiazem malate TABLET, EXTENDED RELEASE;ORAL 020506-003 Oct 4, 1996 ➤ Try a Free Trial ➤ Try a Free Trial
Merck TIAMATE diltiazem malate TABLET, EXTENDED RELEASE;ORAL 020506-003 Oct 4, 1996 ➤ Try a Free Trial ➤ Try a Free Trial
Merck TIAMATE diltiazem malate TABLET, EXTENDED RELEASE;ORAL 020506-001 Oct 4, 1996 ➤ Try a Free Trial ➤ Try a Free Trial
Merck TIAMATE diltiazem malate TABLET, EXTENDED RELEASE;ORAL 020506-002 Oct 4, 1996 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
US Army
Argus Health
Chinese Patent Office
Baxter
Federal Trade Commission
Julphar
Accenture
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.